Literature DB >> 16496168

A cost utility analysis of the right method for screening hemoglobin E among Thai pregnant women.

Viroj Wiwanitkit1.   

Abstract

BACKGROUND: Inherited hemoglobin disorders are an important problem in many developing countries including Thailand. Of the several inherited hemoglobin disorders, hemoglobin E (HbE) (beta 26, GAG-AAG, Glu-Lys) is the most common hemoglobinopathy in Thailand. Presently, screening to identify carriers of hemoglobin disorders among pregnant subjects is an interesting topic in antenatal care in Thailand. Of late, many trials have been conducted to identify the right screening methods for the detection of hemoglobin disorders among Thai pregnant women. The common screening methods include red blood cell (RBC) index determination, application of mathematical model and hemoglobin electrophoresis.
METHODS: Here, the author presents an evaluation of the cost utility of those tests in medical practice in Thailand. The cost/utility of hemoglobin electrophoresis is the highest followed by RBC index determination, application of mathematical model and DCIP test.
RESULTS: Here, it can be shown that the cost per accurate diagnosis for DCIP is the least expensive.
CONCLUSION: It is interesting to note that DCIP also posed high sensitivity in the screening for HbE disorder. Therefore, this test is the best method for screening the population, particularly pregnant women, to identify carriers of hemoglobin disorders. It should be recommended as part of antenatal care in Thailand as well as its neighbouring countries which have a similar high rate of HbE disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16496168     DOI: 10.1007/s00404-006-0134-2

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  2 in total

Review 1.  Hemoglobin E disorder: Newborn screening program.

Authors:  Viroj Wiwanitkit
Journal:  Indian J Hum Genet       Date:  2013-07

2.  Cost-effectiveness analysis for triple markers serum screening for Down's syndrome in Thai setting.

Authors:  Viroj Wiwanitkit
Journal:  Indian J Hum Genet       Date:  2014-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.